Past Events
Invited Speakers
Allison Waters
Assistant Professor of Psychiatry and Neuroscience · Icahn School of Medicine at Mount Sinai
The Waters Lab develops and tests innovative brain measures and electrical neuromodulation strategies to optimize neuropsychiatric care. Our aim is to supercharge rehabilitation efforts for individuals battling depression, OCD, and various neurological disorders. In both my research and clinical practice at Mount Sinai, I am dedicated to a future where psychotherapy and neurotechnology converge seamlessly. Biometric tools, advanced neurotech, psychedelics and cool gadgets are increasingly accessible to consumers; it is now critical that we identify the physiological signals that offer actionable insights to those seeking transformative change in their lives.
Debina Sarkar
Assistant Professor, · MIT Media Lab
Deblina Sarkar is a trans-disciplinary innovator, initially trained in electrical engineering and physics and then, has traversed the realm of biology, driven by curiosity and belief that truly disruptive technologies can immerge at the interface of diverse research arenas. Her inventions include, among others, a 6-atom thick channel quantum-mechanical transistor overcoming fundamental power limitations, an ultra-sensitive label-free biosensor, technology revealing previously invisible biological nanostructures of brain and the first ultra-miniaturized antenna that operates inside a living cell in 3D environment.
Greg Kubin
Investing in Frontier Brain Tech · PsyMed Ventures
Greg Kubin serves as a General Partner at PsyMed Ventures, where he leads investments in frontier brain technologies and mental health innovations, focusing on early-stage companies that advance neuroscience and psychological treatments. With a background in venture capital and healthcare, Kubin has achieved notable success in identifying and funding transformative startups in the neurotech sector, including several that have progressed to clinical trials. His expertise lies in bridging finance with scientific advancements in brain health, emphasizing ethical AI applications in mental health diagnostics. Kubin also co-hosts the Business Trip podcast, where he discusses emerging trends in tech and investment, contributing to broader industry conversations on innovation in neurotechnology.
Jacob Robinson
CEO and Co-Founder · Motif Neurotech
Co-Founder of Motif Neurotech, building therapeutic brain computer interfaces for mental health diseases. Professor in Electrical & Computer Engineering and Bioengineering at Rice University where his group develops miniature technologies to manipulate and monitor physiology and neural circuit activity.
Jon Nelson
Cofounder · Neurolive
Jon Nelson is a seasoned healthcare communications executive with over 20 years of experience in the biopharmaceutical industry, where he has transitioned into a prominent mental health advocate and lived-experience expert. Having battled severe depression for much of his life, Nelson achieved remission through deep brain stimulation (DBS), a groundbreaking procedure that not only saved his life but also fueled his mission to combat mental health stigma and support others facing similar challenges. As co-founder and Chief Lived Experience Officer of Neurolive, a consulting firm dedicated to integrating lived experience perspectives into mental health, wellness, and neurological product development, he collaborates with neuroscientist Dr. Rachel Wurzman to amplify patient voices in the industry. Additionally, Nelson serves as Director of Lived Experience at Motif Neurotech, advises nonprofits such as One Mind and the Mental Health Collaborative, and speaks at national forums, including NIH congressional briefings, to advance mental health awareness. Born and raised in Pittsburgh, Pennsylvania, he resides in Newtown, PA, with his wife Barbara and their three children.
Nathalie Gouailhardou
CEO and Founder · Neurode
Nathalie Gouailhardou is the CEO and Founder of Neurode, a company focused on developing wearable headsets for brain imaging and stimulation, with applications in treating conditions like ADHD. She brings expertise in neurotechnology and neuroscience, having led innovative projects in non-invasive brain interfaces. Gouailhardou's background includes founding Neurode to advance mental health solutions through hardware and software integration. Her achievements encompass securing funding for Neurode and contributing to research in wearable neurotech devices. This work highlights her dedication to improving brain health technologies.